1. Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ. Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. Diabetes Care. 2006; 29:2114–2116. PMID:
16936162.
2. International Diabetes Federation. IDF diabetes atlas. 6th ed. Brussels: International Diabetes Federation;2013.
3. Won JC, Lee JH, Kim JH, Kang ES, Won KC, Kim DJ, et al. Diabetes fact sheet in Korea, 2016: an appraisal of current status. Diabetes Metab J. 2018; 42:415–424. PMID:
30113146.
Article
4. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352:837–853. PMID:
9742976.
5. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000; 321:405–412. PMID:
10938048.
Article
6. Diabetes Control and Complications Trial Research Group. Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329:977–986. PMID:
8366922.
Article
7. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009; 360:129–139. PMID:
19092145.
Article
8. Murray P, Chune GW, Raghavan VA. Legacy effects from DCCT and UKPDS: what they mean and implications for future diabetes trials. Curr Atheroscler Rep. 2010; 12:432–439. PMID:
20652839.
Article
9. Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med. 2008; 359:1565–1576. PMID:
18784091.
Article
10. Ha KH, Kim DJ. Current status of managing diabetes mellitus in Korea. Korean J Intern Med. 2016; 31:845–850. PMID:
27604796.
Article
11. Carls G, Huynh J, Tuttle E, Yee J, Edelman SV. Achievement of glycated hemoglobin goals in the US remains unchanged through 2014. Diabetes Ther. 2017; 8:863–873. PMID:
28646411.
Article
12. Tai TY, Chuang LM, Tsai ST. Diabcare (Taiwan) Study Group. Treatment of type 2 diabetes mellitus in a primary care setting in Taiwan: comparison with secondary/tertiary care. J Formos Med Assoc. 2006; 105:105–117. PMID:
16498504.
Article
13. Lim DJ, Kwon HS, Kim HS, Lee JH, Ko SH, Lee JM, et al. Clinical characteristics of the diabetic patients managed at the different medical institutions in Seoul and Gyeonggi province. Korean J Med. 2006; 71:173–181.
14. Harris SB, Ekoe JM, Zdanowicz Y, Webster-Bogaert S. Glycemic control and morbidity in the Canadian primary care setting (results of the diabetes in Canada evaluation study). Diabetes Res Clin Pract. 2005; 70:90–97. PMID:
15890428.
Article
15. Park YH. Strategy for noncommunicable disease control and prevention. J Korean Med Assoc. 2014; 57:808–814.
Article
16. Health Insurance Review & Assessment Service. Comprehensive quality report on diabetes. Wonju: HIRA;2017.
18. Korean Diabetes Association. Treatment guideline for diabetes. Seoul: KDA;2019.
19. Ko SH, Han K, Lee YH, Noh J, Park CY, Kim DJ, et al. Past and current status of adult type 2 diabetes mellitus management in Korea: a National Health Insurance Service Database analysis. Diabetes Metab J. 2018; 42:93–100. PMID:
29676539.
Article
20. Korean Diabetes Association. Diabetes fact sheet in Korea 2018. Seoul: KDA;2018.
21. Introduction: standards of medical care in diabetes. 2018. Diabetes Care. 2018; 41(Suppl 1):S1–S2. PMID:
29222369.
22. Yoo KH, Shin DW, Cho MH, Kim SH, Bahk HJ, Kim SH, et al. Regional variations in frequency of glycosylated hemoglobin (HbA1c) monitoring in Korea: a multilevel analysis of nationwide data. Diabetes Res Clin Pract. 2017; 131:61–69. PMID:
28689084.
Article
23. Liu Y, Zupan NJ, Shiyanbola OO, Swearingen R, Carlson JN, Jacobson NA, et al. Factors influencing patient adherence with diabetic eye screening in rural communities: a qualitative study. PLoS One. 2018; 13:e0206742. PMID:
30388172.
Article
24. van Eijk KN, Blom JW, Gussekloo J, Polak BC, Groeneveld Y. Diabetic retinopathy screening in patients with diabetes mellitus in primary care: incentives and barriers to screening attendance. Diabetes Res Clin Pract. 2012; 96:10–16. PMID:
22137363.
Article
25. Byun SH, Ma SH, Jun JK, Jung KW, Park B. Screening for diabetic retinopathy and nephropathy in patients with diabetes: a nationwide survey in Korea. PLoS One. 2013; 8:e62991. PMID:
23667557.
Article
26. Zgibor JC, Songer TJ, Kelsey SF, Weissfeld J, Drash AL, Becker D, et al. The association of diabetes specialist care with health care practices and glycemic control in patients with type 1 diabetes: a cross-sectional analysis from the Pittsburgh epidemiology of diabetes complications study. Diabetes Care. 2000; 23:472–476. PMID:
10857937.
Article
27. Zgibor JC, Songer TJ. External barriers to diabetes care: addressing personal and health systems issues. Diabetes Spectr. 2001; 14:23–28.
Article